×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TOVX – theriva biologics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TOVX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
09:49 am
tovx
SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (???, Tokkyocho, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes [Yahoo! Finance]
Low
Report
SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan's Patent Office (???, Tokkyocho, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes [Yahoo! Finance]
11/12
08:37 am
tovx
Theriva Biologics GAAP EPS of -$6.81 [Seeking Alpha]
Medium
Report
Theriva Biologics GAAP EPS of -$6.81 [Seeking Alpha]
11/12
08:00 am
tovx
Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results
High
Report
Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results
10/31
04:05 pm
tovx
Theriva Biologics Selected as Finalist in International Competition for Merck KGaA's EMEA Advance Biotech Grant
High
Report
Theriva Biologics Selected as Finalist in International Competition for Merck KGaA's EMEA Advance Biotech Grant
10/16
08:00 am
tovx
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma
Medium
Report
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma
10/3
09:17 am
tovx
Theriva Biologics up on positive DSMC review in SYN-004 trial for transplant recipients [Seeking Alpha]
Medium
Report
Theriva Biologics up on positive DSMC review in SYN-004 trial for transplant recipients [Seeking Alpha]
10/3
08:00 am
tovx
Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
High
Report
Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
9/26
09:06 pm
tovx
Theriva Biologics Announces Pricing of $2.5 Million Public Offering
High
Report
Theriva Biologics Announces Pricing of $2.5 Million Public Offering
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
04:43 pm
tovx
Form S-8 Theriva Biologics, Inc.
Low
Report
Form S-8 Theriva Biologics, Inc.
11/12
09:48 am
tovx
Form 10-Q Theriva Biologics, Inc. For: Sep 30
High
Report
Form 10-Q Theriva Biologics, Inc. For: Sep 30
11/12
09:26 am
tovx
Form 8-K Theriva Biologics, Inc. For: Nov 12
High
Report
Form 8-K Theriva Biologics, Inc. For: Nov 12
11/1
04:05 pm
tovx
Form 8-K Theriva Biologics, Inc. For: Oct 31
Medium
Report
Form 8-K Theriva Biologics, Inc. For: Oct 31
10/16
08:10 am
tovx
Form 8-K Theriva Biologics, Inc. For: Oct 16
Low
Report
Form 8-K Theriva Biologics, Inc. For: Oct 16
10/3
04:12 pm
tovx
Form SC 13G Theriva Biologics, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
Medium
Report
Form SC 13G Theriva Biologics, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
10/3
08:11 am
tovx
Form 8-K Theriva Biologics, Inc. For: Oct 03
Medium
Report
Form 8-K Theriva Biologics, Inc. For: Oct 03
10/2
10:54 am
tovx
Form SC 13G Theriva Biologics, Inc. Filed by: CVI Investments, Inc.
Low
Report
Form SC 13G Theriva Biologics, Inc. Filed by: CVI Investments, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: